New trends in current bariatric-metabolic surgery and their contribution to the treatment of (pre)diabetes
Authors:
Pavol Holéczy 1,2; Matej Pekař 3,4; Marek Bužga 5; Eva Evinová 6
Authors place of work:
Katedra chirurgických oborů, LF OU, Ostrava
1; Chirurgické oddělení Nemocnice AGEL Ostrava-Vítkovice a. s., Ostrava-Vítkovice
2; Fyziologický ústav LF MU, Brno
3; Chirurgické oddělení Nemocnice AGEL Třinec-Podlesí a. s., Třinec
4; Katedra fyziologie a patofyziologie LF OU, Ostrava
5; Gastroenterologické oddělení Nemocnice AGEL Ostrava-Vítkovice a. s., Ostrava-Vítkovice
6
Published in the journal:
Forum Diab 2022; 11(3): 143-150
Category:
Review Article
Summary
Obesity is currently an infamous phenomenon in both the adult and pediatric populations. It has been confirmed that it is connected with many comorbidities that are associated with it in different ways. Conservative treatment of obesity is the domain of obesitologists, diabetologists, nutritional therapists and psychologists. A significant part of conservative treatment also belongs to specialists in movement activity. Surgical treatment is reserved for patients with severe obesity and focuses (not only) on significant weight loss, but also, or especially, on improving comorbidities. Standard surgical procedures are defined, which form a substantial part of the procedures performed. However, innovative (study) operations and endoscopic procedures, of which there are many, are also being put into practice. However, in the long run, they do not achieve the effectiveness and durability of standard operations, yet. The aim of this publication is to introduce current standard surgical procedures and to report on some newer surgical and endoscopic ones. Last, but not least, to familiarize the reader with the latest indication criteria for surgical intervention.
Keywords:
comorbidities – bariatric/metabolic surgery – severe obesity – endoscopic bariatrics
Zdroje
1. Muscogiuri G, Pugliese G, Barrea L et al. Commentary: Obesity: The Achilles heel for COVID-19? Metabolism 2020; 108: 154251. Dostupné z DOI: <http://dx.doi.org/10.1016/j.metabol.2020.154251>.
2. Fried M, Yumuk V, Oppert JM et al. Interdisciplinary European quidelines on metabolic and bariatric surgery. Obes Facts 2013; 6(5): 449–468. Dostupné z DOI: <http://dx.doi.org/10.1159/000355480>.
3. DiLorenzo N, Antoniou SA, Batterham RL et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO‑EC, EASO and ESPCOP. Surg Endoscop 2020; 34(6): 2332–2358. Dostupné z DOI: <http://dx.doi.org/10.1007/s00464–020–07555-y>.
4. Eisenberg D, Shikora SA, Aarts E et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. SOARD 2022; 1–12 (v tlači).
5. Bhandari M, Fobi MAL, Buchwald JN. Bariatric Metabolic Surgery Standardization (BMSS) Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement. Obes Surg 2019; 29(Suppl 4): 309–345. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–019–04032-x>.
6. Welbourn R, Hollyman M, Kinsman R et al. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg 2019; 29(3): 782–795. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–018–3593–1>.
7. Kasalický M, Bařinka A, Čierny M et al. 10 let sleeve gastrectomy v České republice. Rozhl Chir 2016; 95(12): 425–431.
8. Doležalová K, Šrámková P, Fried M. Laparoskopická gastrická plikace v léčbě obezity a metabolických onemocnění. Čas Lék Čes 2020; 159(3–4): 144–146.
9. Holéczy P, Bužga M. Současná bariatricko-metabolická chirurgie. Gastroent Hepatol 2016; 70(6): 485–490.
10. Felsenreich DM, Kefurt R, Schermann M et al. Reflux, Sleeve Dilation, and Barrett’s Esophagus after Laparoscopic Sleeve Gastrectomy: Long-Term Follow-Up. Obes Surg 2017; 27(12): 3092–3101. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–017–2748–9>.
11. Schauer PR, Bhatt DL, Kirwan JP et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes. N Engl J Med 2017; 16; 376(7): 641–651. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1600869>.
12. DeLuca M, Piatto G, Merola G et al. IFSO Update Position Statement on One Anastomosis Gastric Bypass (OAGB). Obes Surg 2021; 31(7): 3251–3278. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–021–05413-x>.
13. Sánchez-Pernaut A, Herrera MA, Ferré N et al. Long-Term Results of Single-Anastomosis Duodeno-ileal Bypass with Sleeve Gastrectomy (SADI-S). Obes Surg 2022; 32(3): 682–689. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–021–05879–9>.
14. Holéczy P. Bariatrická-metabolická chirurgia u diabetikov 2. typu. In: Fábryová Ľ, Holéczy P et al. Diabezita: Diabetes a obezita – nerozlučné dvojičky. Brno: Facta Medica 2019; 133–152. ISBN 978–80–7345–601–6.
15. Angrisani L, Santonicola A, Iovino P et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures. Obes Surg 2018; 28(12): 3783–3794. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–018–3450–2>.
16. Emile SH, Mahdy T, Schou C et al. Systematic review of the outcome of single-anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity with proportion meta-analysis of improvement in diabetes mellitus. Int J Surg 2021; 92: 106024. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijsu.2021.106024>.
17. Melissas J, Taskin HE, Peirasmakis D et al. A Simple Food-Diverting Operation for Type 2 Diabetes Treatment. Preliminary Results in Humans with BMI 28–32 kg/m2. Obes Surg 2017; 27(1): 22–29. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–016–2251–8>.
18. Fried M, Doležalová K, Chambers AP et al. A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway. BMJ Open Diabetes Res Care 2017; 5(1): e000431. Dostupné z DOI: <http://dx.doi.org/10.1136/bmjdrc-2017–000431>.
19. Machytka E, Bužga M, Zonča P et al. Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes. Gastrointest Endosc 2017; 86(5): 904–912. Dostupné z DOI: <http://dx.doi.org/10.1016/j.gie.2017.07.009>.
20. Dargent J. Novel Endoscopic Management of Obesity. Clin Endosc 2016; 49(1): 30–36. Dostupné z DOI: <http://dx.doi.org/10.5946/ce.2016.49.1.30>.
21. Jirapinyo P, McCarty T, Dolan RD et al. Effects of Endoscopic Bariatric and Metabolic Therapies on Nonbalcoholic Fatty Liver Disease: A Systematic Review and Mata-analysis. Clin Gastroenterul Hepatol 2022; 20(3): 511–524. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cgh.2021.03.017>.
22. Ruban A, Asharafian H, Teare JP. The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss. Gastrenterol Res Pract 2018; article ID 7823182. Dostupné z DOI: <https://doi.org.10.1155/2018/7823182>.
23. Reja D, Zhang C, Sarkar A. Endoscopic bariatrics: current therapies and future directions. Transl Gastroenterol Hepatol 2022; 7: 21. Dostupné z DOI: <http://dx.doi.org/10.21037/tgh.2020.03.09>.
24. Gunn AJ, Oklu R. Preliminary Observation of Weight Loss Following Left Gastric Artery Embolization in Humans. J Obes 2014; Article ID 185349. Dostupné z DOI: <http://dx.doi.org/10.1155/2014/185349>.
25. Alvarez-Cordero R. Will we still be cutting in the 21st century? Obes Surg 2005; 15(10): 1366–1367. Dostupné z DOI: <http://dx.doi.org/10.1381/096089205774859218>.
26. Česká obezitologická společnost. Informace dostupné z WWW: <https://www.obesitas.cz/pro-pacienty/?#map>.
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Forum Diabetologicum
2022 Číslo 3
Najčítanejšie v tomto čísle
- New criteria for the diagnosis of gestational diabetes mellitus and their consequences
- The status of SGLT2 inhibitors in the current EASD/ADA 2022 therapeutic recommendations for the treatment of type 2 diabetes mellitus and their use in practice: case reports and commentary
- New trends in current bariatric-metabolic surgery and their contribution to the treatment of (pre)diabetes
- Presence and near future of pharmacological treatment of obesity/diabesity